Dthera Sciences is working to create a truly innovative digital therapeutic to meaningfully improve the quality of life and reduce loneliness in those with Alzheimer’s Disease, Dementia, and Senior Isolation.

Cognoa’s digital diagnostics and personalized therapeutics improve the timeliness, scale, and effectiveness of behavioral healthcare. Their first clinically-validated mobile application identified autism on average 13 months earlier than the national average and as early as 18 months – when early intervention has the greatest potential for improved life-long outcomes.

Sanofi Digital Medicine, under the Chief Medical Office, improves patient outcomes through the development of innovative technology-driven solutions that when combined with drugs, improve treatment efficacy, safety, adherence and overall experience.


ProMetrics’ mission is to help biopharma improve patient access to specialty medication and drive brand performance. We leverage unrivaled expertise in data, AI, analytics and technology to provide life sciences decision-makers with the tools to maximize patient outcomes.

IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services focused on helping healthcare clients find better solutions for patients. Formed through the merger of IMS Health and Quintiles, IQVIA applies Human Data Science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes. 

Akili is a prescription digital medicine company combining scientific and clinical rigor with the ingenuity of the tech industry to reinvent medicine. Pioneering the development of digital treatments with direct therapeutic activity and delivered through captivating video game experiences, Akili is advancing a broad pipeline of programs to treat cognitive deficiency.

S3 Connected Health creates Digital Therapeutics and Therapy Management Platforms addressing a range of specialty, rare and general medicine diseases. We leverage behavioral science, connected sensors, medical devices and data analytics to create engaging services that deliver improved healthcare and health economic outcomes.


Believe Limited is a WEBBY-Award winning digital content agency and the top social influencer in several rare disease states, through powerful content like long- and short-form documentary videos, original podcasts, animation and educational videos.


SilverCloud Health is a leading provider of outcomes-based online mental health solutions designed to increase provider capacity, lower costs and provide effective care. Over the course of 10+ years, our clinicians developed evidence-based programs that address conditions such as depression, anxiety and stress, along with chronic conditions.


Multidisciplinary by design, this innovative open access journal bridges the disciplines of computer science, engineering, biomedicine, regulatory science and informatics. The editorial board of this new Karger journal  includes leaders from academia, life sciences, technology and government, thus reflecting the broad scope of the journal.

In 2011, StartUp Health introduced a new model for transforming health by organizing, supporting, and investing in a global army of entrepreneurs called Health Transformers. With the world’s largest digital health portfolio (250+ companies spanning six continents, 20 countries and 70+ cities), StartUp Health is mobilizing this rapidly growing army along with the world’s ‘batteries included’ leaders, innovators, and investors to achieve 10 Health Moonshots, with a 25-year mission to improve the health and wellbeing of everyone in the world.